PanCorVac (Center for Pan-Coronavirus Vaccine Development) — YOSHIHIRO KAWAOKA (UNIVERSITY OF WISCONSIN-MADISON)
SUMMARY Most of the vaccines currently approved or in development against the pandemic SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) virus target immunodominant, strain-specific epitope
| Project title | PanCorVac (Center for Pan-Coronavirus Vaccine Development) |
|---|---|
| Project number | 3P01AI165077-01S1 |
| PI name | YOSHIHIRO KAWAOKA |
| Institution | UNIVERSITY OF WISCONSIN-MADISON |
| Funding mechanism | P01 |
| Agency | NIAID |
| Award amount | $4.62M |
| Fiscal year | 2023 |
| Project start | 2021-09-16T00:00:00 |
| Project end | 2025-08-31T00:00:00 |
| Abstract | SUMMARY Most of the vaccines currently approved or in development against the pandemic SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) virus target immunodominant, strain-specific epitope |
| Key terms | <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV S protein><2019-nCoV spike gl |
$799/mo
Try GrantRadar →